Gross Margin
29.77%vs Specialty Chemicals peers Updated Aug 21, 2026Profit Margin
15.29%vs Specialty Chemicals peers Updated Aug 21, 2026Operating Margin
19.95%vs Specialty Chemicals peers Updated Aug 21, 2026Return on Assets (TTM)
4.09%vs Specialty Chemicals peers Updated Aug 21, 2026Return on Equity (TTM)
13.41%vs Specialty Chemicals peers Updated Aug 21, 2026Revenue (TTM)
16.85BCNY2.51B · vs all stocks (USD) Updated Aug 21, 2026Revenue per Share (TTM)
7.99CNYUpdated Aug 21, 2026Quarterly Revenue Growth
35.30%vs Specialty Chemicals peers Updated Aug 21, 2026Gross Profit (TTM)
4.96BCNY737.98M · vs all stocks (USD) Updated Aug 21, 2026EBITDA (TTM)
3.53BCNY525.13M · vs all stocks (USD) Updated Aug 21, 2026Net Income (TTM)
2.58BCNY382.99M · vs all stocks (USD) Updated Aug 21, 2026Quarterly Earnings Growth (YoY)
44.40%vs Specialty Chemicals peers Updated Aug 21, 2026Operating Cash Flow (TTM)
3.11BCNY463.22M · vs all stocks (USD) Updated Aug 21, 2026Levered Free Cash Flow (TTM)
1.33BCNY197.78M · vs all stocks (USD) Updated Aug 21, 2026Trailing Annual Dividend Rate
0.2300CNYUpdated Aug 21, 2026Trailing Annual Dividend Yield
0.95%Updated Aug 21, 20265-Year Average Dividend Yield
0.86%Updated Aug 21, 2026Payout Ratio
13.93%vs Specialty Chemicals peers Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 18.85%.Updated Aug 21, 2026Minority Interest (Equity)
1.35BCNYFY2025 · Dec 31, 2025Revenue
15.71BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
10.73BCNYFY2025 · Dec 31, 2025Gross Profit
4.98BCNYFY2025 · Dec 31, 2025Operating Income
3.31BCNY492.21M · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
2.95BCNYFY2025 · Dec 31, 2025Income Tax Expense
344.41MCNYFY2025 · Dec 31, 2025Net Income
2.60BCNYFY2025 · Dec 31, 2025EBIT
3.18BCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
4.48BCNYFY2025 · Dec 31, 2025Research & Development
888.24MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
305.70MCNYFY2025 · Dec 31, 2025Other Operating Expenses
145.61MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
140.93MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
235.49MCNYFY2025 · Dec 31, 2025EPS (Basic)
1.12CNYFY2025 · Dec 31, 2025EPS (Diluted)
1.12CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
2.11BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
2.11BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
2.60BCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-245.50MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-3.32BCNYFY2025 · Dec 31, 2025Free Cash Flow
-4.84BCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
5.19BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
2.60BCNYFY2025 · Dec 31, 2025Stock-based Compensation
26.94MCNYFY2025 · Dec 31, 2025Other Non-cash Items
510.71MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-5.91BCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-555.34MCNYFY2025 · Dec 31, 2025Capital Expenditures
-1.51BCNYFY2025 · Dec 31, 2025Purchase of Investments
-3.93BCNYFY2025 · Dec 31, 2025Sale of Investments
2.45BCNYFY2025 · Dec 31, 2025Other Investing Activity
12.00MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-2.97BCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
7.22BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-7.29BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-592.45MCNYFY2025 · Dec 31, 2025Other Financing Charges
54.01MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-616.31MCNYFY2025 · Dec 31, 2025